The ESCMID Emerging Infections Subcommittee and IDSA are co-organising a webinar on the recent Marburg virus outbreak in Rwanda.

• Dr. Louise Mwiseneza, University Teaching Hospital of Kigali, Rwanda - from ESCMID
• Dr. Daniel R. Lucey, Dartmouth Geisel Medical School USA - from IDSA

We will send info on how to register for the webinar in a separate communication, so stay tuned!

Science & Research

The CAREer Grant supports members balancing scientific careers with family responsibilities (childcare) or unexpected situations (illness, caring for elderly parents, etc.). It provides financial assistance to hire qualified support personnel for members who need to reduce their workload or are already working part-time.

Deadline for applications is on 15 January 2025.

The ESCMID AMR Action Subcommittee in collaboration with the TAE organised a 4-part webinar series leading up to and during World AMR Awareness Week this year. All parts are now available for free on demand replay through the ESCMID Academy. Each session explored a different aspect of AMR globally and looking to the future roles that are needed to combat this crisis.

You can see the full programme of events with links to watch on our website. Enjoy!

Education

This esteemed programme offers comprehensive training for healthcare professionals aiming to enhance their expertise in antimicrobial stewardship and combat antimicrobial resistance. Enrolment is limited, and applications will be reviewed through a rigorous selection process.

A few grant spots covering half of the registration fee are available exclusively for ESCMID LMIC members.

In the fast-paced ER environment, timely and precise infection control and antimicrobial decisions are crucial. This immersive module, designed for ER professionals - including doctors, nurses, pharmacists, and infection control teams - will empower you with the best practices for patient safety, screening, isolation, and antimicrobial selection. Our simulation-based approach ensures you’re prepared to apply these skills in real-time, high-stakes settings.

This course is part of the ESCMID EUCIC Certificate Programme.

Congress & Events

Submissions are now open for the 2025 ESCMID Global Art Gallery. The theme this year is Climate Change and Infection. Participants are automatically entered to win one of the incredible prizes offered, and all accepted pieces will be assembled into an art book to be published in January or February 2025.

Artists from around the globe are encouraged to submit their artwork until 31 December 2024.

We are happy to announce that we received once again over 7000 abstract submissions for ESCMID Global 2025. We look forward to seeing your incredible research on display in Vienna in April.

"The overwhelming response of over 7000 abstracts from 125 different countries, demonstrates the truly global reach of our congress, promising to bring the most up-to-date science to Vienna in 2025 " - Jacob Moran Gilad, ESCMID Global Programme Director.

Guidelines & Journals

ESCMID and CMI are currently seeking to fill the role of CMI editor-in-chief from January 2026. For more information on the role, qualifications and application process, see the job advert under Jobs/Talents on the ESCMID webpage.

The open call for applications will close on 31 January 2025.

Wastewater surveillance is a powerful epidemiological tool that “mirrors our life,” and has gained wide attention in recent years due to its application during the COVID-19 pandemic. Hosts Dr. Navaneeth Narayanan and Dr. Emily McDonald are joined by two wastewater surveillance experts, Dr. Nasreen Hassoun-Kheir of Geneva University Hospitals and Professor David Graham of Newcastle University, to discuss how this surveillance method – as well as a multidisciplinary approach – are central to understanding community health, infection control and pandemic preparedness.

Ceftaroline for bloodstream infections caused by methicillin-resistant Staphylococcus aureus: a multicentre retrospective cohort study

Resistance Optimised Antibiotic Dosing (The ROAD Study): Is dosing of meropenem and piperacillin-tazobactam optimised to prevent the emergence of antibiotic resistance safe and feasible in the ICU? A pilot study

Mayo Clinic Observership call is now open!